{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:06:35Z","timestamp":1789477595013,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jpha.2024.101022","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T20:41:01Z","timestamp":1718311261000},"page":"101022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Deep learning-based drug screening for the discovery of potential therapeutic agents for Alzheimer's disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Tong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6296-1737","authenticated-orcid":false,"given":"Pengdi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heshui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2024.101022_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101580","article-title":"Global and regional projections of the economic burden of Alzheimer\u2019s disease and related dementias from 2019 to 2050: A value of statistical life approach","volume":"51","author":"Nandi","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jpha.2024.101022_bib2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer\u2019s disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jpha.2024.101022_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jpha.2024.101022_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/alz.12674","article-title":"Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers","volume":"19","author":"Jessen","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jpha.2024.101022_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jpha.2024.101022_bib6","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa066583","article-title":"Donepezil for the treatment of agitation in Alzheimer\u2019s disease","volume":"357","author":"Howard","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpha.2024.101022_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001191.pub3","article-title":"Rivastigmine for Alzheimer\u2019s disease","author":"Birks","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpha.2024.101022_bib8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/bmj.321.7274.1445","article-title":"Efficacy and safety of galantamine in patients with mild to moderate Alzheimer\u2019s disease: Multicentre randomised controlled trial, Galantamine international-1 study group","volume":"321","author":"Wilcock","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jpha.2024.101022_bib9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer\u2019s disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpha.2024.101022_bib10","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.aau0437","article-title":"Alzheimer\u2019s disease: The right drug, the right time","volume":"362","author":"Golde","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jpha.2024.101022_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: Experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jpha.2024.101022_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.csbj.2019.12.006","article-title":"Machine learning applications in drug development","volume":"18","author":"R\u00e9da","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jpha.2024.101022_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2024.101022_bib14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s43587-023-00415-z","article-title":"Discovering small-molecule senolytics with deep neural networks","volume":"3","author":"Wong","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.jpha.2024.101022_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab211","article-title":"A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2","volume":"22","author":"Wang","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.jpha.2024.101022_bib16","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: Machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jpha.2024.101022_bib17","article-title":"Constituents, pharmacological activities, pharmacokinetic studies, clinical applications, and safety profile on the classical prescription Kaixinsan","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101022_bib18","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0047-6374(01)00309-8","article-title":"Acetylcholinesterase in Alzheimer\u2019s disease","volume":"122","author":"Talesa","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.jpha.2024.101022_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112787","article-title":"A comprehensive review of monoamine oxidase inhibitors as anti-Alzheimer\u2019s disease agents: A review","volume":"206","author":"Manzoor","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpha.2024.101022_bib20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nurt.2008.05.008","article-title":"5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer\u2019s disease","volume":"5","author":"Upton","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jpha.2024.101022_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/ci00057a005","article-title":"SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules","volume":"28","author":"Weininger","year":"1988","journal-title":"J. Chem. Inf. Comp. Sci."},{"key":"10.1016\/j.jpha.2024.101022_bib24","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2024.101022_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9174","article-title":"Strategy for the multi-component characterization and quality evaluation of volatile organic components in Kaixin San by correlating the analysis by headspace gas chromatography\/ion mobility spectrometry and headspace gas chromatography\/mass spectrometry","volume":"35","author":"Yin","year":"2021","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpha.2024.101022_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114385","article-title":"Global identification and determination of the major constituents in Kai-Xin-San by ultra-performance liquid chromatography-quadrupole-Orbitrap mass spectrometry and gas chromatography-mass spectrometry","volume":"206","author":"Lin","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpha.2024.101022_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/acs.jcim.3c01250","article-title":"Chemprop: A machine learning package for chemical property prediction","volume":"64","author":"Heid","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2024.101022_bib28","series-title":"Ensemble methods in machine learning, International Workshop on Multiple Classifier Systems, April 7\u22129, 2000, Cairo, Egypt","author":"Dietterich","year":"2000"},{"key":"10.1016\/j.jpha.2024.101022_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101022_bib30","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0021-9258(18)69497-9","article-title":"A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine","volume":"235","author":"Weissbach","year":"1960","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2024.101022_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1556\/2060.2020.00012","article-title":"Protective effect of fennel, and its major component trans-anethole against social isolation induced behavioral deficits in rats","volume":"107","author":"Raman","year":"2020","journal-title":"Physiol. Int."},{"key":"10.1016\/j.jpha.2024.101022_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11062-019-09801-z","article-title":"Effects of eugenol on Alzheimer\u2019s disease-like manifestations in insulin-and A\u03b2-induced rat models","volume":"51","author":"Taheri","year":"2019","journal-title":"Neurophysiology"},{"key":"10.1016\/j.jpha.2024.101022_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108023","article-title":"Methyl eugenol attenuates liver ischemia reperfusion injury via activating PI3K\/Akt signaling","volume":"99","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jpha.2024.101022_bib34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jep.2014.06.035","article-title":"GC-MS method for determination and pharmacokinetic study of four phenylpropanoids in rat plasma after oral administration of the essential oil of Acorus tatarinowii Schott rhizomes","volume":"155","author":"Wang","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jpha.2024.101022_bib35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/jmf.2012.2739","article-title":"2,4-Di-tert-butylphenol from sweet potato protects against oxidative stress in PC12 cells and in mice","volume":"16","author":"Choi","year":"2013","journal-title":"J. Med. Food"},{"key":"10.1016\/j.jpha.2024.101022_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2016.00280","article-title":"Neurogenesis-promoting natural product \u03b1-asarone modulates morphological dynamics of activated microglia","volume":"10","author":"Cai","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jpha.2024.101022_bib37","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2147\/DDDT.S93559","article-title":"Neuroprotective effect of \u03b2-asarone against Alzheimer\u2019s disease: Regulation of synaptic plasticity by increased expression of SYP and GluR1","volume":"10","author":"Liu","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jpha.2024.101022_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000362689","article-title":"\u03b2-Caryophyllene ameliorates the Alzheimer-like phenotype in APP\/PS1 mice through CB2 receptor activation and the PPAR\u03b3 pathway","volume":"94","author":"Cheng","year":"2014","journal-title":"Pharmacology"},{"key":"10.1016\/j.jpha.2024.101022_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0161-813X(03)00097-4","article-title":"Clinical pharmacology of MAO inhibitors: Safety and future","volume":"25","author":"Yamada","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jpha.2024.101022_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110887","article-title":"Melatonin regulates A\u03b2 production\/clearance balance and A\u03b2 neurotoxicity: A potential therapeutic molecule for Alzheimer\u2019s disease","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpha.2024.101022_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molimm.2019.09.020","article-title":"Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2\/TLR4\/NF-\u03baB pathways in BV2 cells","volume":"116","author":"Zhang","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jpha.2024.101022_bib42","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11064-017-2217-9","article-title":"5-HT6 receptor agonist and antagonist against \u03b2-amyloid-peptide-induced neurotoxicity in PC-12 cells","volume":"42","author":"Bokare","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jpha.2024.101022_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phymed.2017.04.003","article-title":"Pharmacology and toxicology of \u03b1- and \u03b2-asarone: A review of preclinical evidence","volume":"32","author":"Chellian","year":"2017","journal-title":"Phytomedicine"}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924001199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924001199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T02:28:43Z","timestamp":1730514523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177924001199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2095177924001199"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101022","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep learning-based drug screening for the discovery of potential therapeutic agents for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101022"}}